Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Not Necessarily. If you read the CC transcript the final results for the scar trial, eye trial, and samcyprone won't happen until mid 2017. But those are for the final results.

the company revealed that before the end of the year they will release cohort 1 & 2 together with Cohort 3 & 4 with added doses as preliminary results/pictures. Also for the eye trial they will also release safety and early efficacy for that as well. So actually results will be available before then. Hopefully the scar results impress this time around. The last scar results showed a 68% improvement with RXI-109 treatment. My hope is to see this time an 85% to 90% improvement. That would be a game changer IMO, to improve scars by that much if that is the next result. We shall see what happens the next go around. GL to all